Health Care: Drugs

Clovis Oncology Inc (CLVS: NASDAQ)

$64.55 -1.50 | -2.28%
06/19/13 - 04:00 PM ET
Company Balance Sheet
Dec 2012 Dec 2011
Assets
Cash and Equivalents 144.10M 138.24M
Receivables 0.00 0.00
Inventories 0.00 0.00
Other Current Assets 659.00K 247.00K
Total Current Assets 144.87M 141.52M
Property, Plant & Equipment, Gross 1.59M 2.17M
Accumulated Depreciation & Depletion 508.00K 274.00K
Property, Plant & Equipment, Net 1.08M 1.90M
Intangibles 0.00 0.00
Other Non-Current Assets 38.00K 34.00K
Total Non-Current Assets 1.12M 1.93M
Liabilities & Shareholder Equity
Total Assets 145.99M 143.44M
Accounts Payable 2.30M 3.04M
Short Term Debt 0.00 0.00
Other Current Liabilities 0.00 0.00
Total Current Liabilities 12.16M 11.00M
Long Term Debt 0.00 0.00
Deferred Income Taxes 0.00 0.00
Other Non-Current Liabilities 338.00K 656.00K
Minority Interest 0.00 0.00
Total Non-Current Liabilities 338.00K 656.00K
Total Liabilities 12.50M 11.65M
Preferred Stock Equity 0.00 0.00
Common Stock Equity 133.50M 131.79M
Common Par 26.00K 22.00K
Additional Paid In Capital 317.90M 242.22M
Cumulative Translation Adjustment 0.00 0.00
Retained Earnings -184.48M -110.50M
Treasury Stock 0.00 0.00
Other Equity Adjustments 53.00K 49.00K
Total Capitalization 133.50M 131.79M
Total Equity 133.50M 131.79M
Total Liabilities & Stock Equity 145.99M 143.44M
Total Common Shares Outstanding 26.21M 22.38M
Preferred Shares 0.00 0.00
Treasury Shares 0.00 0.00
Basic Weighted Shares Outstanding 24.92M 3.85M
Diluted Weighted Shares Outstanding 24.92M 3.85M
Number of Employees 61 57
Number of Part-Time Employees 0 0

Portfolios with CLVS

View All

Latest CLVS Headlines from TheStreet

More Financial News for CLVS

Press Releases for CLVS

See All Press Releases

Partner Headlines for CLVS

brokerage partners
watch thestreet tv
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter